Published in Chem Res Toxicol on September 01, 2001
The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. Psychopharmacology (Berl) (2007) 2.25
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit (2008) 1.29
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) (2004) 1.22
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos (2009) 1.15
Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. J Clin Psychopharmacol (2008) 1.01
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl) (2003) 1.01
A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol (2005) 1.01
Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.94
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol (2005) 0.94
Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Anal Bioanal Chem (2009) 0.88
3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry. Anal Chim Acta (2014) 0.88
Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Ther Drug Monit (2009) 0.88
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos (2013) 0.85
Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine. J Mass Spectrom (2011) 0.85
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats. Br J Pharmacol (2014) 0.84
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J Anal Toxicol (2009) 0.84
Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers. Chem Res Toxicol (2008) 0.81
Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.80
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology (Berl) (2012) 0.80
Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans. PLoS One (2016) 0.78
Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clin Chem (2011) 0.78
Possible mechanisms for induction of oxidative stress and suppression of systemic nitric oxide production caused by exposure to environmental chemicals. Environ Health Prev Med (2002) 0.77
Determination of the role of calcium on instability of neurotoxic metabolite of ecstasy by HPTLC-mass. Daru (2013) 0.75
Recombinant human erythropoietin treatment in patients on maintenance home haemodialysis. Lancet (1989) 2.61
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
[Treatment of homozygotic familial hypercholesterolemia with continuous apheresis of low density lipoproteins]. Med Clin (Barc) (1991) 1.94
Control of hypertension in coronary heart disease. Int J Cardiol (2008) 1.93
An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med (2000) 1.72
Immediate and follow-up results of transluminal balloon dilation for discrete subaortic stenosis. J Am Coll Cardiol (1991) 1.68
Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation (1998) 1.63
Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol (1991) 1.60
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol (2000) 1.55
Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol (2000) 1.54
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther (1999) 1.49
CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res (1994) 1.49
Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing. Anal Bioanal Chem (2010) 1.42
Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients. Am J Kidney Dis (1997) 1.42
Balloon valvuloplasty for mild mitral stenosis. Cathet Cardiovasc Diagn (1991) 1.42
Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause? Nephron (1989) 1.41
Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome. Environ Health Perspect (2001) 1.41
Dialysis in patients with bilateral nephrectomy for transitional cell carcinoma. Nephron (1995) 1.40
Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients. Nephron (1996) 1.39
Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol (1990) 1.38
Membranoproliferative glomerulonephritis and hepatitis C virus infection. Nephron (1993) 1.38
Effect of melatonin on myocardial oxidative stress induced by experimental obstructive jaundice. Rev Esp Enferm Dig (2009) 1.38
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia]. Med Clin (Barc) (2001) 1.38
Fatal oxalic acid poisoning from sorrel soup. Lancet (1990) 1.38
[Adrenal insufficiency in patients with kidney failure secondary to amyloidosis. Its detection by a stimulation test]. Rev Clin Esp (1994) 1.37
Percutaneous interventions on severe coarctation of the aorta: a 21-year experience. Pediatr Cardiol (2005) 1.33
Gingival enlargement induced by drugs. Drug Saf (1996) 1.32
Balloon-expandable stent repair of severe coarctation of aorta. Am Heart J (1995) 1.29
Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am J Cardiol (1999) 1.28
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend (2001) 1.22
Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend (1994) 1.20
Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol (2001) 1.20
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) (2004) 1.20
Incidence and prognosis of acute renal failure in older patients. J Am Geriatr Soc (1990) 1.20
Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect (2000) 1.20
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J Clin Psychopharmacol (2000) 1.18
Interspecific hybridization increases transposition rates of Osvaldo. Mol Biol Evol (1999) 1.16
Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol (1994) 1.13
Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin Chem (2000) 1.12
Pharmacology of MDMA in humans. Ann N Y Acad Sci (2000) 1.12
Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther (1993) 1.11
Effect of alendronate on cultured normal human osteoblasts. Bone (1998) 1.10
Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Invest (2001) 1.09
Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids (1997) 1.07
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther (2000) 1.05
Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem (2001) 1.03
A transiting giant planet with a temperature between 250 K and 430 K. Nature (2010) 1.03
In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol (1997) 1.03
Molecular cytogenetic and genomic insights into chromosomal evolution. Heredity (Edinb) (2011) 1.01
The absorption and elimination of metoclopramide in three animal species. J Pharm Pharmacol (1976) 1.00
Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin. Antimicrob Agents Chemother (1982) 0.98
Reliability of two measurement indices for gingival enlargement. J Periodontal Res (2012) 0.98
[Brucellosis and portal thrombosis]. Rev Esp Enferm Dig (1990) 0.98
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des (2012) 0.98
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl (1999) 0.97
The elderly patient with acute renal failure. J Am Soc Nephrol (1995) 0.96
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther (1997) 0.96
Obliteration of femoral pseudoaneurysm complicating coronary intervention by direct puncture and permanent or removable coil insertion. Am J Cardiol (1997) 0.96
Renovascular hypertension in children. Scand J Urol Nephrol (2001) 0.96
Cardiac tamponade complicating mitral balloon valvuloplasty. Am J Cardiol (1991) 0.95
Acute effects of tramadol in methadone-maintained volunteers. Drugs (1994) 0.94
Monte carlo simulation of 3-D buffered Ca(2+) diffusion in neuroendocrine cells. Biophys J (2000) 0.94
Steroid-dependent nephrotic syndrome with minimal glomerular changes and mesangial IgA deposits. Child Nephrol Urol (1989) 0.93
Bacteraemia with Cedecea neteri in a patient with systemic lupus erythematosus. Postgrad Med J (1995) 0.93
Combined percutaneous atrial septal defect occlusion and pulmonary balloon valvuloplasty in adult patients. Tex Heart Inst J (2000) 0.93
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther (2001) 0.93
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol (2008) 0.92
Transcatheter occlusion of complex atrial septal defects. Catheter Cardiovasc Interv (2000) 0.91
High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome. Transplant Proc (2007) 0.91
Immunomodulatory effects of dietary intake of chitin on gilthead seabream (Sparus aurata L.) innate immune system. Fish Shellfish Immunol (2001) 0.91
Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis. Postgrad Med J (1994) 0.91
Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrol (1990) 0.91
Prognosis of children with acute renal failure: a study of 138 cases. Nephron (1993) 0.90
Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol (1999) 0.90
[Job satisfaction and burnout in general practitioners]. Aten Primaria (2003) 0.90
Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur J Clin Nutr (2002) 0.89
Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Ann N Y Acad Sci (2002) 0.88